{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:04:56Z","timestamp":1792757096281,"version":"4.5.0"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T00:00:00Z","timestamp":1719187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>To evaluate different cardiovascular magnetic resonance (CMR) parameters for the differentiation of light chain amyloidosis (AL) and transthyretin-related amyloidosis (ATTR).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>In total, 75 patients, 53 with cardiac amyloidosis {20 patients with AL [66 \u00b1 12 years, 14 males (70%)] and 33 patients with ATTR [78 \u00b1 5 years, 28 males (88%)]} were retrospectively analysed regarding CMR parameters such as T1 and T2 mapping, extracellular volume (ECV), late gadolinium enhancement (LGE) distribution patterns, and myocardial strain, and compared to a control cohort with other causes of left ventricular hypertrophy {LVH; 22 patients [53 \u00b1 16 years, 17 males (85%)]}. One-way ANOVA and receiver operating characteristic analysis were used for statistical analysis. ECV was the single best parameter to differentiate between cardiac amyloidosis and controls [area under the curve (AUC): 0.97, 95% confidence intervals (CI): 0.89\u20130.99, P &amp;lt; 0.0001, cut-off: &amp;gt;30%]. T2 mapping was the best single parameter to differentiate between AL and ATTR amyloidosis (AL: 63 \u00b1 4 ms, ATTR: 58 \u00b1 2 ms, P &amp;lt; 0.001, AUC: 0.86, 95% CI: 0.74\u20130.94, cut-off: &amp;gt;61 ms). Subendocardial LGE was predominantly observed in AL patients (10\/20 [50%] vs. 5\/33 [15%]; P = 0.002). Transmural LGE was predominantly observed in ATTR patients (23\/33 [70%] vs. 2\/20 [10%]; P &amp;lt; 0.001). The diagnostic performance of T2 mapping to differentiate between AL and ATTR amyloidosis was further increased with the inclusion of LGE patterns [AUC: 0.96, 95% CI: (0.86\u20130.99); P = 0.05].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>ECV differentiates cardiac amyloidosis from other causes of LVH. T2 mapping combined with LGE differentiates AL from ATTR amyloidosis with high accuracy on a patient level.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjci\/jeae154","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T13:04:33Z","timestamp":1719234273000},"page":"1451-1461","source":"Crossref","is-referenced-by-count":14,"title":["Parametric mapping using cardiovascular magnetic resonance for the differentiation of light chain amyloidosis and transthyretin-related amyloidosis"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0331-2045","authenticated-orcid":false,"given":"Dmitrij","family":"Kravchenko","sequence":"first","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]},{"name":"Quantitative Imaging Lab Bonn (QILaB), University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2016-6166","authenticated-orcid":false,"given":"Alexander","family":"Isaak","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]},{"name":"Quantitative Imaging Lab Bonn (QILaB), University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1531-2088","authenticated-orcid":false,"given":"Sebastian","family":"Zimmer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II-Cardiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5419-2488","authenticated-orcid":false,"given":"Can","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine II-Cardiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narine","family":"Mesropyan","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]},{"name":"Quantitative Imaging Lab Bonn (QILaB), University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon M","family":"Bischoff","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]},{"name":"Quantitative Imaging Lab Bonn (QILaB), University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilia","family":"Voigt","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]},{"name":"Quantitative Imaging Lab Bonn (QILaB), University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ginzburg","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Attenberger","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus C","family":"Pieper","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Kuetting","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]},{"name":"Quantitative Imaging Lab Bonn (QILaB), University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7715-4636","authenticated-orcid":false,"given":"Julian A","family":"Luetkens","sequence":"additional","affiliation":[{"name":"Department of Diagnostic and Interventional Radiology, University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]},{"name":"Quantitative Imaging Lab Bonn (QILaB), University Hospital Bonn , Venusberg-Campus 1, 53127 Bonn ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,24]]},"reference":[{"key":"2024093014475317900_jeae154-B1","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet"},{"key":"2024093014475317900_jeae154-B2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/13506129.2018.1549825","article-title":"Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"25","author":"Benson","year":"2018","journal-title":"Amyloid"},{"key":"2024093014475317900_jeae154-B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10741-023-10339-w","article-title":"Sex differences in transthyretin cardiac amyloidosis","volume":"29","author":"Aimo","year":"2023","journal-title":"Heart Fail Rev"},{"key":"2024093014475317900_jeae154-B4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40119-022-00265-7","article-title":"Sex differences in wild-type transthyretin amyloidosis: an analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"11","author":"Campbell","year":"2022","journal-title":"Cardiol Ther"},{"key":"2024093014475317900_jeae154-B5","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1148\/rg.2020190069","article-title":"Trends in diagnostic imaging of cardiac amyloidosis: emerging knowledge and concepts","volume":"40","author":"Oda","year":"2020","journal-title":"Radiographics"},{"key":"2024093014475317900_jeae154-B6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"2024093014475317900_jeae154-B7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11864-020-00738-8","article-title":"Advances in the treatment of cardiac amyloidosis","volume":"21","author":"Macedo","year":"2020","journal-title":"Curr Treat Options Oncol"},{"key":"2024093014475317900_jeae154-B8","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"key":"2024093014475317900_jeae154-B9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcmg.2022.07.008","article-title":"Multi-imaging characterization of cardiac phenotype in different types of amyloidosis","volume":"16","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024093014475317900_jeae154-B10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mrm.20110","article-title":"Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart","volume":"52","author":"Messroghli","year":"2004","journal-title":"Magn Reson Med"},{"key":"2024093014475317900_jeae154-B11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12968-015-0127-z","article-title":"Gradient Spin Echo (GraSE) imaging for fast myocardial T2 mapping","volume":"17","author":"Sprinkart","year":"2015","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024093014475317900_jeae154-B12","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.acra.2007.06.017","article-title":"Phase-sensitive inversion recovery single-shot balanced steady-state free precession for detection of myocardial infarction during a single breathhold","volume":"14","author":"Huber","year":"2007","journal-title":"Acad Radiol"},{"key":"2024093014475317900_jeae154-B13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjcard.2023.06.022","article-title":"How often does apical sparing of longitudinal strain indicate the presence of cardiac amyloidosis?","volume":"202","author":"Wali","year":"2023","journal-title":"Am J Cardiol"},{"key":"2024093014475317900_jeae154-B14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1161\/hc0402.102975","article-title":"Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association","volume":"105","author":"Cerqueira","year":"2002","journal-title":"Circulation"},{"key":"2024093014475317900_jeae154-B15","doi-asserted-by":"crossref","first-page":"E419","DOI":"10.1148\/radiol.2021211162","article-title":"Cardiac MRI in patients with prolonged cardiorespiratory symptoms after mild to moderate COVID-19","volume":"301","author":"Kravchenko","year":"2021","journal-title":"Radiology"},{"key":"2024093014475317900_jeae154-B16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"key":"2024093014475317900_jeae154-B17","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and extracellular volume in transthyretin amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024093014475317900_jeae154-B18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcmg.2019.03.026","article-title":"Noncontrast magnetic resonance for the diagnosis of cardiac amyloidosis","volume":"13","author":"Baggiano","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024093014475317900_jeae154-B19","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/01.RES.0000126569.75419.74","article-title":"Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress","volume":"94","author":"Brenner","year":"2004","journal-title":"Circ Res"},{"key":"2024093014475317900_jeae154-B20","doi-asserted-by":"crossref","first-page":"19813","DOI":"10.1074\/jbc.M116.736736","article-title":"Cell damage in light chain amyloidosis: FIBRIL INTERNALIZATION, TOXICITY AND CELL-MEDIATED SEEDING","volume":"291","author":"Marin-Argany","year":"2016","journal-title":"J Biol Chem"},{"key":"2024093014475317900_jeae154-B21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024093014475317900_jeae154-B22","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native T1 mapping, extracellular volume mapping, and late gadolinium enhancement in cardiac amyloidosis: a meta-analysis","volume":"13","author":"Pan","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024093014475317900_jeae154-B23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12968-018-0478-3","article-title":"Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis","volume":"20","author":"Ridouani","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024093014475317900_jeae154-B24","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00330-011-2109-3","article-title":"Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis","volume":"21","author":"Wassmuth","year":"2011","journal-title":"Eur Radiol"},{"key":"2024093014475317900_jeae154-B25","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/jmri.21918","article-title":"Quantitative assessment of myocardial T2 relaxation times in cardiac amyloidosis","volume":"30","author":"Sparrow","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"2024093014475317900_jeae154-B26","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jcmg.2020.07.030","article-title":"Novel cardiovascular magnetic resonance model to distinguish immunoglobulin light chain from transthyretin cardiac amyloidosis","volume":"14","author":"Slivnick","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024093014475317900_jeae154-B27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024093014475317900_jeae154-B28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"2024093014475317900_jeae154-B29","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.2015141744","article-title":"Differential myocyte responses in patients with cardiac transthyretin amyloidosis and light-chain amyloidosis: a cardiac MR imaging study","volume":"277","author":"Fontana","year":"2015","journal-title":"Radiology"},{"key":"2024093014475317900_jeae154-B30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jcmg.2018.02.016","article-title":"Cardiac structural and functional consequences of amyloid deposition by cardiac magnetic resonance and echocardiography and their prognostic roles","volume":"12","author":"Knight","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"2024093014475317900_jeae154-B31","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation"},{"key":"2024093014475317900_jeae154-B32","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic resonance in transthyretin cardiac amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2024093014475317900_jeae154-B33","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"7-8","key":"2024093014475317900_jeae154-B34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00508-018-1411-3","article-title":"Comparison of native myocardial T1 and T2 mapping at 1.5T and 3T in healthy volunteers: reference values and clinical implications","volume":"131","author":"Granitz","year":"2019","journal-title":"Wien Klin Wochenschr"},{"key":"2024093014475317900_jeae154-B35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12968-019-0595-7","article-title":"Z-score mapping for standardized analysis and reporting of cardiovascular magnetic resonance modified look-locker inversion recovery (MOLLI) T1 data: normal behavior and validation in patients with amyloidosis","volume":"22","author":"Kranzusch","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024093014475317900_jeae154-B36","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mrm.27421","article-title":"Establishing intra- and inter-vendor reproducibility of T1 relaxation time measurements with 3T MRI","volume":"81","author":"Lee","year":"2019","journal-title":"Magn Reson Med"},{"key":"2024093014475317900_jeae154-B37","doi-asserted-by":"crossref","first-page":"100004","DOI":"10.1016\/j.jocmr.2023.100004","article-title":"Inter-scanner comparability of Z-scores for native myocardial T1 and T2 mapping","volume":"26","author":"Razzaq","year":"2024","journal-title":"J Cardiovasc Magn Reson"},{"key":"2024093014475317900_jeae154-B38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12350-022-02960-3","article-title":"Quantitative 99mTc-DPD-SPECT\/CT assessment of cardiac amyloidosis","volume":"30","author":"Kessler","year":"2023","journal-title":"J Nucl Cardiol"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeae154\/58465391\/jeae154.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/25\/10\/1451\/59459099\/jeae154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/25\/10\/1451\/59459099\/jeae154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T14:48:09Z","timestamp":1727707689000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/25\/10\/1451\/7697853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,24]]},"references-count":38,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,6,24]]},"published-print":{"date-parts":[[2024,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeae154","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,6,24]]}}}